Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Screening to Prophylax Against Clostridium Difficile Infection

NCT02996487 is registered in ClinicalTrials.gov with Corewell Health East as lead sponsor.

NCT NCT02996487
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02996487 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Screening to Prophylax Against Clostridium Difficile Infection
Lead sponsor
Corewell Health East
Phase
Phase 4
Overall status
Completed
Start date
December 19, 2016
Completion date
June 28, 2023
Enrollment
1,294 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

clostridium difficile infection